PONTE VEDRA, Fla. – November 6, 2026 – Treace Medical Concepts, Inc. ("Treace" or the "Company") (NasdaqGS: TMCI), a medical technology company with the goal of being the recognized leader in the surgical treatment of bunions and other foot & ankle conditions, today reported financial results for the third quarter ended September 30, 2026. Recent Highlights "We are encouraged by our third quarter performance, reflecting accelerated double-digit case volume growth and continued market share gains – driven by ...